TAM
ONC

Tocqueville Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Tocqueville Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,515
Closed -$212K – 798
2018
Q4 		$212K Sell
1,515
-3,475
-70% -$461K ﹤0.01% 691
2018
Q3 		$859K Buy
4,990
+3,490
+233% +$587K 0.01% 528
2018
Q2 		$231K Hold
1,500
– – ﹤0.01% 760
2018
Q1 		$252K Buy
+1,500
New +$203K ﹤0.01% 735

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Tocqueville Asset Management's ONC Position: Q1 2019 in Review

Tocqueville Asset Management sold out of BeOne Medicines Ltd (ONC) in Q1 2019, closing a stake of 1,515 shares — an estimated $212K sold.

Tocqueville Asset Management first reported a position in ONC in Q1 2018 and held it in 4 quarters. The position peaked at $859K in Q3 2018. 199 funds tracked by Wall St. Rank hold ONC as of Q1 2019.

  • Tocqueville Asset Management reported no remaining BeOne Medicines Ltd position as of Q1 2019 after selling out during the quarter.
  • Tocqueville Asset Management sold 1,515 BeOne Medicines Ltd shares in Q1 2019, an estimated $212K.
  • Tocqueville Asset Management first reported a position in BeOne Medicines Ltd in Q1 2018 and held it in 4 quarters.
  • Tocqueville Asset Management's BeOne Medicines Ltd position peaked at $859K in Q3 2018.
  • 199 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2019.

Based on Tocqueville Asset Management's 13F filing for Q1 2019, filed 30 Apr 2019.